BD buys MedKeeper for $93M to continue expansion into pharmacy technology

BD buys MedKeeper for $93M to continue expansion into pharmacy technology

  • Technology
  • July 29, 2022
  • No Comment
  • 71
  • 6 minutes read


This audio is automatically generated. Please let us know if you have any comments.

Dive brief:

  • Becton Dickinson has acquired MedKeeper to continue the push into pharmacy technologies that began with its recent $1.53 billion purchase from Parata Systems.
  • The purchase of MedKeeper will add cloud-based pharmacy management applications to BD’s portfolio of technologies to support the preparation of compounded medications.
  • BD is paying $93 million to acquire MedKeeper from drugmaker Grifols, which bought the company in 2020. Grifols is selling the business as part of a plan to exit “non-strategic activities.”

Diving knowledge:

Last month, BD agreed to buy Parata for technology to automate the filling, packaging and central filling of vials. Analysts framed the technology as complementary to BD’s Pyxis automated drug dispensers, adding that Parata could support the company’s goal of improving its operating margins by 2025.

The purchase of MedKeeper moves BD into another part of the pharma technology market. MedKeeper sells a photo-based medication workflow system that is designed to document all steps of the IV preparation process, making them available for remote review and approval by the pharmacist. MedKeeper presents the technology as a way to improve efficiency and ensure compliance with compounding regulations.

Mike Garrison, global president of medication management solutions at BD, said the software is well-suited to the demands of today’s pharmaceutical environment, where “labor shortages impacted by COVID and changes in regulatory requirements have further exacerbated the need for customizable pharmacy software solutions.” In light of the pressures, Garrison sees the need to change old practices.

“Length and manual procedures that might once have been ‘good enough’ can now be replaced and augmented by software that allows pharmacists to deliver a higher level of care,” the BD executive said in a statement.

The acquisition is one of several made by BD this year, with the purchase of Parata preceded by the acquisition of flow cytometry business Cytognos. BD also made a slew of acquisitions last year.



Source link

Related post

EDUCAUSE 2022: How Data Collection Can Improve Student and Faculty IT Support

EDUCAUSE 2022: How Data Collection Can Improve Student and…

At Indiana University, Gladdin said, to make life easier for students and faculty, they implemented a course template for the Canvas…
UGC, AICTE warn students against online PhD programmes offered by EdTech platforms | Latest News India

UGC, AICTE warn students against online PhD programmes offered…

The University Grants Commission (UGC) and the All India Council for Technical Education (AICTE) on Friday issued a joint advisory against…
UGC, AICTE warn students against online PhD programmes offered by EdTech platforms | Latest News India

UGC, AICTE warn students against online PhD programmes offered…

The University Grants Commission (UGC) and the All India Council for Technical Education (AICTE) on Friday issued a joint advisory against…

Leave a Reply

Your email address will not be published.